A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.

Lukey, Pauline T; Harrison, Stephen A; Yang, Shuying; Man, Yim; Holman, Beverley F; Rashidnasab, Alaleh; Azzopardi, Gabrielle; Grayer, Michael; Simpson, Juliet K; Bareille, Philippe; Paul, Lyn; Woodcock, Hannah V; Toshner, Richard; Saunders, Peter; Molyneaux, Philip L; Thielemans, Kris; Wilson, Frederick J; Mercer, Paul F; Chambers, Rachel C; Groves, Ashley M; Fahy, William A; Marshall, Richard P; Maher, Toby M.
Eur Respir J; 53(3)2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30765508

Não foram localizados documentos relacionados